Sylentis CDMO
Sylentis is a European CDMO specializing in the development and manufacturing of therapeutic oligonucleotides. With nearly 20 years of experience and a state-of-the-art facility near Madrid, we offer flexible production capacity, advanced synthesis platforms, and robust analytical and regulatory support. Our integrated approach—from early development to regulatory submission—helps clients accelerate their path to market with confidence.
